Immunological Biomarkers in Tuberculosis Management

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

September 10, 2026

Study Completion Date

October 10, 2026

Conditions
TuberculosisTuberculosis Infection
Interventions
OTHER

Multiple blood samples

Patients with active tuberculosis will have 5 research-specific blood samples: V1, (baseline) immediately before initiating anti-tuberculosis treatment, then 4 samples during anti-tuberculosis treatment and follow-up, i.e. at 48 hours (V2), 15 days (V3), 2 months (V4) and 6 months (V5) after initiation of treatment. The total volume of each sample will be 20 mL for a total of 100 mL.

OTHER

Single blood sample

Patients with Latent tuberculosis infection will have a single specific sample of 14 mL.

Trial Locations (1)

69004

RECRUITING

Service des Maladies Infectieuses - Hôpital de la Croix Rousse - Hospices Civils de Lyon, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER